The United States pharma & health products industry is the largest addressable market in its category globally, generating roughly $720 billion in annual revenue across the fifty states. US pharma & health products is the world's largest pharmaceutical market, anchored by Pfizer, J&J, Merck, Eli Lilly, plus fast-growing biotech (Moderna, Vertex, Regeneron) and medical device (Medtronic, Abbott, Stryker). Consolidation runs alongside a long tail of regional and specialty operators — every state carries active players plus a mid-market layer that rarely appears in a single register.
For B2B sales and research teams — SaaS platforms, enterprise vendors, distributors, staffing agencies, market-research firms — the addressable universe is enormous but scattered across state registrations, industry associations, and public disclosures. Our verified US pharma & health products directory consolidates the discoverable operators into a single CSV kept fresh against FDA + CMS + DEA disclosures and industry-body updates. Buyers often pair this dataset with our US Healthcare, US Manufacturing and US Wholesale & Distribution catalogs when building multi-vertical outreach.
Overview
Market shape at a glance
The US pharma & health products economy is anchored by Pfizer, Johnson & Johnson, Merck, Eli Lilly, AbbVie, Bristol-Myers Squibb, Amgen, Gilead, Biogen, Regeneron, Vertex, Moderna, plus generics (Teva US, Sandoz US, Mylan/Viatris), plus device (Medtronic, Abbott, Stryker, Boston Scientific, Zimmer Biomet). Combined, the top-tier operators capture the majority of tracked revenue, but the growth frontier sits with mid-market brands, franchise networks, and challenger startups building direct-to-consumer or vertical-SaaS motions. Aggregate spend crossed $720 billion in the most recent fiscal year.
Who regulates what
- FDA — drug + device approval
- CMS — Medicare drug pricing (IRA)
- DEA — controlled substances
- CDC — vaccines + public health
- IRB + HHS — clinical research oversight
Geography
Density concentrates in Northeast (NJ, NY, MA, PA) for pharma HQs; San Diego + San Francisco Bay Area for biotech; Minneapolis (Medtronic). Every state carries active operators; enterprise sales teams typically prioritize metro coverage first, then Tier-2 and secondary markets where competitive noise is lower and buyer intent is easier to isolate.
Industries in this group
Sub-verticals we cover
Top brands + operators
The category is anchored by Pfizer, Johnson & Johnson, Merck, Eli Lilly, AbbVie, each competing across national retail chains, wholesale distribution, and direct-to-consumer channels.
Mid-market + specialty
Beyond the top-tier operators, the mid-market layer covers Bristol-Myers Squibb, Amgen, Gilead, Biogen plus regional and specialty players who serve specific customer segments the majors don't prioritize.
Distribution + retail
Distribution and retail partners are the primary channel for the pharma & health products category, with major national chains and independent operators moving product volume every day.
Services + adjacencies
Related services — installation, service partners, distribution warehouses, and adjacent categories — round out the ecosystem and represent a significant secondary sales opportunity.
How buyers use this data
How buyers use this dataset
- Brand distribution: Sign retailers, distributors, and franchise partners as B2B accounts for the pharma & health products category.
- SaaS platforms: POS, inventory, CRM, and workforce-management tools for operators.
- Franchise expansion: Map white-space cities and metro areas where existing operator density is lower relative to buyer demand.
- BNPL and consumer finance: Enable payment financing at point of sale for higher-ticket purchases.
- Insurance embedded: Extended warranty, accident, and product-return insurance distributed through operators.
- M&A and investor sourcing: Regional operators and specialty firms ripe for consolidation.
Pricing in United States
Licensing & pricing
US pharma & health products datasets are priced dynamically by row count from our country pricing table. The Regular license covers the immediately downloadable slice — typically 45–50% of the full record set — and is the most economical entry point for territory pilots. The Extended license unlocks every verified record and permits internal redistribution across your team. Both formats ship as CSV or Excel with 95%+ verified fields (name, address, city, state, ZIP, phone, website; GPS on Extended). Refresh cadence is monthly for headline datasets and quarterly for long-tail sub-verticals.
Get started
Browse the Pharma & Health Products datasets below, or contact our team for a bespoke slice — a specific state, a specific sub-vertical, or a specific employee-count band. Sample rows are on every product page. For adjacent coverage, see US Healthcare, US Manufacturing, US Wholesale & Distribution.
Frequently asked questions
How large is the US pharma & health products market?
Who regulates the pharma & health products sector in the US?
What data is included per record?
Are Tier-2 and Tier-3 metros covered as well as major cities?
How often is the data refreshed?
Written in the voice of a US business journalist.
Reader comments
Be the first to share your thoughts on Pharma & Health Products in United States.